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Epidemiology is the study ofepidemics. The primary goal ofepidemiological studies should be
the identification of the determinants of disease in order to decrease morbidity and mortality.
Epidemiological studies evolve through descriptive, analytical, and experimental approaches. The
traditional infectious disease epidemiology studies were primarily concerned with identification of
an agent, incubation period, mode of transmission, population at risk, and methods of disease
control. Chronic disease epidemiology has tended to emphasize a more complex interaction of
independent and dependent disease variables that resulted in a greater need for statistical
methodology. There has been relatively little interest in chronic disease epidemiology either in
modes of disease transmission or in incubation periods. Chronic disease epidemiology has also
focused more on analytical epidemiology than on experimental, clinical trials.
Many chronic diseases are probably caused by living organisms such as viruses. The
fundamental difference in methodology may relate to length ofincubation period. Chronicdisease
epidemiology should probably build more on successful methods ofinfectious disease epidemiolo-
gy, especially modes of disease transmission, host susceptibility, incubation periods, and clinical
trials. The concept of multifactorial etiology of many chronic diseases may be a measure ofour
ignorance ofcausality rather than a biological principle.
Epidemiology is a popular term. It is sometimes difficult to recognize an epidemio-
logical study. The traditional epidemic investigation ofan infectious disease may have
little resemblance to the complex multivariate analysis in chronic disease epidemiolo-
gy, or the clinical epidemiologist evaluating the efficacy of some specific therapy, the
utilization of a drug, or the behaviors of physicians in the practice of medicine.
Epidemiology is becoming synonymous with any health or medical studies in humans
which include both a numerator and a denominator.
A clinician may describe 30 cases of a specific disease in great detail. When this
description is defined in relation to a specific hospital population over a defined time
period, it becomes clinical epidemiology. A variety of interesting and probably
important statistical tools, widely used in the social science fields, have been rediscov-
ered by the epidemiologist and have become part of the jargon of epidemiological
methods. Even in our best epidemiological journals, papers appear in which the simple
rate of an event or proportion is no longer presented, but only the result of regression
analysis. The reader generally hopes and tries to believe that the simple rates and
proportions common to epidemiological studies, a logical first step in any analysis, have
been done prior to the regression analysis, and that the editors of these journals are
attempting to save space by excluding much if not all of the basic analyses.
There should be a common thread in the epidemiological investigation (Table 1).
Infectious disease epidemiology is not remarkably different from chronic or clinical
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TABLE 1
The Epidemiology Investigation
Is there an epidemic?
I
Yes
What is the population at risk?
I
What is the mode oftransmission?
What is the possible etiology?
I
What is the attack rate?
What is the spectrum ofdisease?
I
What is the incubation period?
I
What are the methods tocontrol or to eliminate the epidemic?
I
How effective are the control procedures?
epidemiology when this common approach to epidemiology is followed. Table 1
describes what I believe is the common base of the epidemiology investigation.
Epidemiology is the study of epidemics. The definition of an epidemic is the increase
above an expected value for an event. That event can be an infectious disease, a higher
incidenceofmortality from achronicdisease, a greater frequency ofhospitalization for
a certain disease, a higher case-fatality percentage, or even the greater utilization ofa
diagnostic procedure. The first step in any investigation or in any epidemiological
study, however, should be a statement as to the definition ofthe epidemic.
In infectious disease epidemiology, this descriptive epidemiological phase depends
predominantly on surveillance of either geographic or temporal variations in disease
(Table 2). Because ofthe relatively short incubation periods of many infectious diseases,
wideoscillations indiseasefrequencyoverrelativelyshortperiodsoftimeareoften noted in
the community, and thus the surveillance ofdisease in defined communities over time is
the cornerstone ofdescriptive infectious disease epidemiology.
The study of chronic disease also depends on a measurement of geographic or
temporal distributions of disease. Unfortunately, available morbidity data is often
absent, incomplete, or inaccurate; thus, until recently much of chronic disease
descriptive epidemiology depended on quantification of mortality statistics in relation
to time, place, and person. Mortality statistics depend on both the incidence of a
disease and the case-fatality percentage. The chronic disease epidemiologist spends an
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TABLE 2
Is There an Epidemic?
Descriptive Epidemiology
Acute Diseases Chronic Diseases
1. Surveillance ofgeographic or temporal varia- 1. Geographic distribution ofmorbidity and mor-
tions tality by host characteristics
a. Short incubation periods often lead to wide 2. Temporal trends in disease
oscillation ofdisease measured by incidence a. Long incubation periods and absence of
or attack rates in community. morbidity data result in emphasis on mor-
tality statistics dependent on both incidence
and case fatality.
b. Prevalent rather than incident cases usually
studied
inordinate amount oftime and effort trying to interpret both the geographic variations
and trends in specific diseases. Has cancer increased in the population during the past
30 or 40 years because of the introduction of many environmental carcinogens, or has
the apparent incidence increased only because ofbetterdiagnosis and ascertainment of
cases, while the mortality statistics have remained relatively flat [1]? Possibly the
incidence has increased, but with improved treatment the case-fatality rate has fallen.
The modern chronic disease epidemiologist has, unfortunately, spent too little time
improving methods ofcollecting descriptive epidemiology and attempting to define the
epidemic clearly. The only chronic disease that is well defined in terms of descriptive
epidemiology in the United States and in other countries is cancer [2]. Only in selected
communities such as Rochester, Minnesota, and the like, have serious attempts been
made to quantify the epidemic ofchronic disease [3].
The second key question in an epidemiological investigation is the determinants of
the population at risk (Table 3). The infectious disease model tries to identify the
population at risk in relation to the probability ofexposure to the suspected vehicle of
disease transmission, such as food, water, air, insect, and so on, and the host
susceptibility to infectious disease, often based on prior immunity or selected social
demographic characteristics and, more recently, on certain genetic markers. These
measures ofsusceptibility have broken down as we recognize the increasing latency of
infection and the incorporation ofthe viral genotype into the host DNA.
In chronic disease epidemiology, the populations at risk are moredifficult to identify
and generally are defined in very broad terms, usually social demographic characteris-
tics, specific occupational groups, and so forth. Often, in infectious disease epidemiolo-
gy, the population at risk is defined prior to disease onset either through the
identification of a historical cohort, such as all the individuals attending a specific
event, or individuals exposed to a specific water supply. In chronic disease epidemiolo-
gy, the population is defined either at the time ofdisease, that is, as a measure of the
mortality rates, or the prevalence ofdisease in a defined community. The probability of
exposure to a potential etiological agent or vehicle of transmission of disease is much
more difficult to define in chronic diseases. For example, until recent years much ofour
occupational and environmental epidemiology depended predominantly on the mea-
surement of specific occupations with a large group of individuals and comparison of
mortality rates within that occupational group either to the general population or toLEWIS H. KULLER
TABLE 3
What Is the Population at Risk?
Descriptive Epidemiology
Acute Diseases Chronic Diseases
1. Population at risk often defined in terms of 1. Population at risk defined in broad terms,
probability ofexposure to suspected vehicle of usually social demographic characteristics, oc-
disease transmission and host susceptibility cupation
based on prior immunity 2. Population at risk usually defined at time of
2. Population at risk usually defined prior to dis- disease as prevalence or mortality
ease onset 3. Probability ofexposure usually defined in very
general terms
another occupational population. The degree of exposure within the specific occupa-
tion was only loosely defined, and specific measurements ofexposure were not ofhigh
priority. More recently, chronic disease epidemiologists have become more aware of
the need better to define the specific populations at risk in relation to potential
exposures. Greater emphasis is now placed on actual measurement of exposure of
workers or of potentially exposed individuals to an environmental hazard by utilizing
classical industrial hygiene methods or, more preferably, by direct quantification of
individual exposures [4,5]. We can expect a substantial improvement in the identifica-
tion of specific environmental exposure and better determination of risk as new
techniques are applied to identify individual as opposed to aggregate estimates of
exposure.
The third step in the epidemiological investigation is the analysis of the mode of
transmission of the etiological agent or vehicle in the population (Table 4). In
infectious disease epidemiology, this component is of primary importance. Epidemics
are defined in terms ofcommon source, person-to-person, indirect orvector-borne, and
vertical transmission. The primary emphasis in analytical infectious diseaseepidemiol-
ogy is often in the study of the mode of transmission of the disease. Cases will be
compared to controls by potential exposure to a common source, to individuals who are
infectious, or to an indirect vector oftransmission. Analysis ofdisease distributions in
relation to geographic area, time, and personal characteristics aim primarily to
understand the mode of transmission as an important clue in the search for the
etiological agent.
Surprisingly, in chronic disease epidemiology, almost no emphasis is placed on the
mode of transmission. Few of the modern textbooks, primarily on chronic disease
epidemiology, even discuss the concept of mode of transmission in relation to the
epidemiological investigation. The primary emphasis in chronic disease epidemiology
has been on the attempt to identify the relationships between selected independent and
dependent variables such as disease. Remarkably, the chronic disease epidemiologist
has spent relatively little time attempting to understand how these independent
variables may relate to the dependent variable with respect to mode of disease
transmission. Yet clearly we can classify chronic disease by mode of transmission of
either the vehicle or the etiological agent in exactly the same way as in infectious
diseases. Coronary atherosclerotic heart disease is most likely a classical example ofa
common source epidemic (diet, cholesterol, and saturated fat), and insulin-dependent
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TABLE 4
What Is the Mode of Transmission?
Analytical Epidemiology
Acute Diseases Chronic Diseases
1. Method ofdisease transmission is ofprimary 1. Little emphasis on mode oftransmission
importance: 2. Primary emphasis in chronic disease epidemi-
-common source ology is to identify relationships between inde-
-person to person pendent and dependent variables such as dis-
-indirect: vector ease.
-vertical
2. Primary emphasis in analytical epidemiology
is on mode oftransmission:
a. Case-control studies seek mode oftransmis-
sion as clue to vehicle and etiology.
diabetes, a person-to-person transmitted infectious disease, a virus or viruses [6,7].
Lung cancer can be considered to be an example of a common source, continuous
exposure epidemic (cigarette smoking); cervical cancer (and AIDS), venereal diseases
[8,9,10]. Chronic disease epidemiology methods would be substantially improved if a
new emphasis on the mode of transmission of the disease became a cornerstone of the
research effort.
The next step in the epidemiological investigation is the attempt to identify the
possible etiology of disease (Table 5). Infectious disease epidemiology evolved in the
era ofa single agent for a single disease. Theclassical case-control studies in infectious
disease epidemiology were generally a comparison ofserological evidence of infection
or some tissue fingerprint or marker ofthe agent between defined cases versus suitab'e
controls. Thecontrols were usually selected on the basisofprobabilityofbeing exposed
to the agent ofinterest. Relative risks were usually substantial ifthespecific agent that
wascausal had been properlyidentified, which was especially truein thosesituations in
which not only clinical but also subclinical disease could be identified.
The second approach in infectious disease epidemiology was to compare exposure to
the possible vehicle oftransmission, such as a common water supply, food chain, insect
vector, and so on, between cases and controls. For example, in the study of the
epidemiology ofacquired immunedeficiency syndrome, the twokey components ofthe
case-control studies have been, first, the evidence of infection with human immune
deficiency virus, i.e., serological comparison between cases and controls; and, second,
the comparison of possible mode of transmission such as receptive anal intercourse,
blood transfusions, and contaminated blood factors between cases and controls.
In chronic disease epidemiology, on the other hand, the emphasis has often not been
on the identification of a specific etiological agent, but rather primary emphasis on
host environmental relationships. The identification of the specific etiological agent
has been difficult because ofthe potential complex interrelationships between the host
and avarietyoffactors that may lead todisease. Therelative risks that areidentified in
case-control studies are usually at relatively low magnitude. The reason for this fact is
that most ofthese measures are either a surrogate marker ofthe true etiological agent
or are not determined accurately. We may compare an occupational history (that is,
farmers versus non-farmers among individuals with non-Hodgkin's lymphoma) andLEWIS H. KULLER
TABLE 5
What Is the Possible Etiology of the Disease?
Study Design
Acute Diseases Chronic Diseases
1. Primary emphasis on agent: 1. Primary emphasis on host environment:
Case-Control: Case-Control:
a. Comparison ofprevalence ofserological a. Classical-case-control studies:
marker ofagent or tissue fingerprint of 1. Usually low-order relative risks because
agent between defined cases vs. controls ofidentification ofsurrogate measure of
2. Comparison ofhistory ofexposure to possible etiology
vehicle oftransmission among cases vs. con- 2. Difficult to separate exposure between
trols cases and controls
3. Emphasis on statistical methods to eval-
uate multiple independent variables
find a slightly elevated (at most twofold) excess relative riskamong farmers. Similarly,
we may then evaluate exposure to pesticides between cases and controls [11]. The
degree of exposure to the pesticide or the specific chemical that may be the causal
agent for non-Hodgkin's lymphoma is often difficult, ifnot impossible, to identify.
In chronic disease epidemiology, because of the long incubation period, it is often
difficult truly to separate exposure between cases and controls. Thus, chronic disease
epidemiology depends on a probability estimate of the likelihood of exposure of the
cases versus the controls, and such measures as duration ofexposure and possible dose.
Markers ofindividual exposure, such as serological evidence ofprior viral infection or
actual identification of individual measurement of exposure to a specific vehicle, are
often lacking. It is possible that without good measures ofexposure between cases and
controls the success ofchronic disease epidemiology studies is substantially limited. A
primary goal in chronic disease epidemiology may, therefore, be an attempt to improve
our methods ofmeasuring prior exposure to the possible etiological agent. The studies
of exposures to Agent Orange in Vietnam are probably a classic example [12]. The
failures initially to beableactually to measuredioxin amongpotentially exposed troops
has substantially limited studies of possible Agent Orange exposure to disease. Only
recently has it become apparent that the measurement ofdioxin levels in tissues many
years after the exposure may provide the most important step in the epidemiological
evaluation of the relationship between possible Agent Orange, dioxin exposure, and
selected diseases.
Theuseofsurrogate measures ofexposure to aspecific etiological agent often results
in difficult analytical problems that require sophisticated statistical methods in order
to evaluate the independent effects ofmultiple variables. Many times in these analyses
more than one of the independent variables is acting as a surrogate measure of the
specific etiological agent. For example, a simple measure such as level ofeducation is a
surrogate marker for a variety of health habits which are either directly or inversely
correlated with level of education, such as cigarette smoking, alcohol intake, dietary
factors, and the like. Level ofeducation is alsooften a marker for income anddegree of
and availability of medical care, which could be a primary determinant of the
likelihood that the disease of interest could be identified. The evaluation ofconfound-
ing, variables which in some way are affecting both the distribution ofthe independent
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TABLE 6
What Is the Possible Etiology of the Disease?
Study Designa
Acute Diseases: Chronic Diseases:
Longitudinal Longitudinal
1. Sero-epidemiology: 1. Prospective or historical cohort studies to eval-
a. Risk ofdisease over time sero-negative- uate risk ofdisease. Major problems include
sero-positive stability ofrisk factors, low incidence ofdis-
b. Relationship between sero-conversion and ease, long incubation period, difficulty ofmea-
disease suring prior exposure, especially dose.
c. Family studies-secondary attack rates
'Continued from Table 5
and dependent outcomes, has become one of the most important and controversial
components ofchronic disease epidemiological methodology. Unfortunately, relativel3
few studies have evaluated whether such statistical techniques have added to our
understanding of the etiology of disease or only to a refinement of statistical
methodology for the analysis ofindependent variables.
Longitudinal, prospective studies in infectious disease epidemiology have been
relatively limited until recent years (Table 6). The most interesting and important
longitudinal studies have been the use of serum banks to evaluate the risks of disease
among sero-negative or sero-positive individuals to a specific agent over time or the
relationship between sero-conversion to a specific agent and subsequent risk ofdisease
[13]. These studies have also been expanded to look at other serological, cellular, and
tissue markersofpossible infection and subsequent risksofdisease. The relatively short
incubation period of many ofthe infectious diseases and the successful ability to store
at least serum and, perhaps, now cells have offered an excellent opportunity for these
types of longitudinal studies. Another interesting and important component of
longitudinal studies in infectious disease epidemiology has been the family studies or
the attempt to measure secondary attack rates within families as a way ofdetermining
the transmission of the agent, infectivity, pathogenicity of the agent, and the
incubation period [14].
Longitudinal studies in chronic disease epidemiology are very limited by the long
incubation period of many of the diseases, their relatively low incidence, and the
difficulties of maintaining surveillance. Thus, many of the true longitudinal studies
have been restricted to cardiovascular disease, especially coronary heart disease.
Longitudinal studies in coronary artery disease have many similarities to the sero-
epidemiological longitudinal studies in infectious diseases. Risk factors, in this case
levels ofsome factor in the blood such as blood cholesterol, are measured at a specific
point in time or repeatedly over time, and the subsequent risk ofdisease is determined
in relation to the levels of the risk factors. In recent years, sero-epidemiological
approaches, including development ofserum banks ofstored specimens for subsequent
analysis, have become useful in chronic disease epidemiological studies as well [15].
The longitudinal studies ofthe etiology ofbreast cancer are now collecting and storing
blood, cells, and other tissue markers among healthy high-risk women with the hope of
subsequently analyzing selected specimens among new cases of breast cancer and
selected controls [16,17]. This approach should receive the highest priority inLEWIS H. KULLER
subsequent chronic disease epidemiological studies. These techniques, directly carried
over from infectious disease epidemiology, have great potential in chronic disease
epidemiology, especially as improved methodology evolves for the storage of serum,
cells, and so on.
The classical historical cohort evolved from occupational epidemiology in an
attempt to utilize information that had not been previously collected for epidemiologi-
cal study purposes. Such studies have proven extremely important in many of our
occupational investigations. The data, however, have been substantially restricted by
the paucity ofinformation about individual exposures and the identification ofspecific
etiological agents among a mixture of various chemicals and other environmental
factors that may be related to subsequent disease.
Once a disease has been identified and there is some evidence ofthespecific etiology,
then a major concern in infectious disease epidemiology is the determination of the
attack rate or the incidence of the disease (Table 7). Specific agents are defined in
terms of their infectivity or the probability of causing infection, the pathogenicity in
terms ofcausing disease, and the virulence or the severity ofdisease. Susceptibility to
infection or to disease is often determined in relation to prior immunity and selected
host and genetic characteristics. As noted, the secondary attack rate becomes an
important measure of both estimation of risk, that is, the attack rate, and also an
understanding ofthe modes oftransmission and the incubation period. Concepts such
as virulence and pathogenicity are rarely discussed in chronic disease epidemiology.
Incidence rates are usually measured either cross-sectionally, i.e., from registries, or in
specific, defined, longitudinal population studies. Cumulative incidence is a measure of
an individual's risk of disease over a specific period of time and in some ways is more
closely akin to an estimation of the attack rate over time in infectious disease
epidemiology.
The measurement ofsecondary attack rate in chronic disease epidemiology, that is,
secondary cases in the family, is usually equated with some genetic risk rather than the
potential spread ofan etiological agentwithin thefamily [18]. Clearly, secondary cases
within a family are confounded by both the shared genes and environment. In many of
the chronic disease studies, the environmental as compared to the genetic component
have been difficult to separate. Genetic epidemiology has begun to evolve new
techniques to look specifically at genotypic as opposed to phenotypic markers. The
development ofthese new techniques, including restriction, fragment-length polymor-
phisms, and identification ofthe DNA ofthe specific genes, can provide very powerful
tools for the study of genetic, environmental interactions such as the relationship
between dietary intake of cholesterol and LDL, Apo-B levels and risk of heart attack,
or specific immuno-genetic markers and response to infectious agents. The possible
interaction of genetic and environmental factors within the family will become easier
to study.
It is, perhaps, surprising that comparative incidence measures among populations
and various subgroups within populations are very important components ofinfectious
disease epidemiology problems and have played a relatively small role in most chronic
disease epidemiology. Clearly, part ofthe problem has been the difficulties ofadequate
ascertainment of incident disease across populations and both the low incidence and
long incubation periods. Yet the striking differences in the incidence of both insulin-
dependent and non-insulin-dependent diabetes, selected cancers, and coronary heart
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TABLE 7
What Is the Attack Rate or Incidence of Disease?
Acute Diseases Chronic Diseases
1. Attack rate usually measured in terms ofinci- 1. Incidence measured either cross-sectionally,
dence ofnew cases: Also measured by proba- i.e., registries, or from defined longitudinal
bility ofinfection-infectivity, pathogenicity, studies.
and virulence ofagent Incomplete and biased ascertainment a major
Susceptibles often can be well defined. problem
2. Secondary attack rate important measure to 2. Secondary attack rate usually considered a
estimate both risk and mode oftransmission measure ofgenetic risk
disease have provided some of the strongest evidence for an understanding of the
possible etiology ofthese diseases [19,20,21].
Theunderstanding ofthe spectrum ofdisease from subclinical toclinical and fatal is
an important component of infectious disease epidemiology (Table 8). Serological
methods to identify subclinical disease have played an important role in infectious
disease epidemiology in attempting to understand disease transmission and identifica-
tion ofthe specific etiological agent.
In chronic disease epidemiology, the measurement of subclinical disease is very
difficult and is often not evaluated. Many of the controls in the classical case-control
studies have subclinical manifestations ofthe disease ofinterest. This fact is especially
true in the studies of cardiovascular disease, diabetes, and probably many of the
cancers among older individuals at least. The inability to differentiate subclinical from
clinical disease, and from non-disease, may be one of the factors that lead to a
conservative or reduced estimation ofrisk in many chronic disease studies. Interesting-
ly, in infectious disease epidemiology the ability to identify the risk factors that
determine subclinical versus clinical disease has not been very successful. Age at time
of infection and certain general host characteristics have provided only weak markers
of the determinant of the spectrum of disease. Searches for specific host or genetic
characteristics as well as other environmental factors that may contribute to the
severity of the disease process have not been a successful mainstream component of
infectious disease epidemiology, at least until recent times.
In chronic disease epidemiology, on the other hand, the determinants ofthe natural
TABLE 8
What Is the Spectrum of Disease?
Acute Diseases Chronic Diseases
1. Spectrum from subclinical to clinical-very 1. Measurement of,subclinical disease very diffi-
important-serological methods played an im- cult and often not evaluated. Many controls
portant role in epidemiological studies. have subclinical disease, reducing risk esti-
2. Ability to determine risk factors for subclini- mates ofstudies.
cal vs. clinical disease not very successful 2. Determinants of natural history ofdisease, i.e.,
from mild to severe to death, and efficacy of
therapies are often a very important compo-
nent ofresearch (clinical epidemiology).
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history of the disease from mild, to severe, to death, and the efficacies of specific
therapies have been a very important component of research and, in fact, form the
basis ofclinical epidemiology. The use ofepidemiological methods in the evaluation of
clinical care has probably substantially enhanced the field ofclinical medicine.
The early infectious diseaseepidemiologist evolved outofthe concerns for control of
the spread of infectious diseases in the community, with a primary emphasis on
modifying the modes of disease transmission and, subsequently, prevention of disease
by active and passive immunization or by environmental controls. The new breed of
chronic disease epidemiologists may be evolving out of the clinical concerns about the
effective treatment of chronic diseases and the need for an active preventive approach
which depends on understanding of the specific etiologies and modes oftransmission.
The determination ofthe incubation period of a specific disease is also an important
component ofinfectious disease epidemiological research (Table 9). Knowledge ofthe
incubation period is important in understanding the etiologyofdisease and themodeof
transmission. Knowledge ofthe period ofinfectivity in relation to the incubation period
is of critical importance in disease control and prevention. Dr. Philip Sartwell
published a series of interesting and important papers describing methods of estimat-
ing the distribution of the incubation period and pointed out that usually there was a
log-normal distribution, that the median rather than the mean was the best measure of
the incubation period, and that there seemed to be a specific, and often constant,
dispersion factor of the antilog of the log standard deviation for the specific infectious
diseases [22]. Lilienfeld et al. further utilized Sartwell's methods to evaluate the
incubation periods of selected chronic diseases and showed also that the incubation
periods for some of the chronic diseases were also log-normally distributed with
specific dispersion factors [23]. Surprisingly, however, the incubation period has really
not been a major focus of chronic disease epidemiology, except in cases of common
source events such as unique radiation exposures in Hiroshima or Nagasaki. The
incubation period is hardly discussed in major textbooks ofepidemiology.
In chronic disease epidemiology there appears to be much greater interest in
modeling the evolution of disease and trying to evaluate the interaction between
initiating agents and those that may promote subsequent progression from an earlier
stage to a subsequent clinical disease. Numerous mathematical models have been
generated to study the possible progression ofcancer, based on the number ofchanges
at the cellular level that are necessary forprogression from neoplasia to clinical disease
[24].
A lack of understanding of the concepts of incubation periods may have resulted in
misinterpretation of the relationship between current exposure and disease. Peto and
Doll have pointed out that the modeling of the incubation period of lung cancer from
age at onsetofcigarette smoking to thedevelopment ofdiseaseprobablyexplains much
of the geographic variations and trends in lung cancer among populations [25]. The
absence of any knowledge of incubation period of a chronic disease often makes it
practically impossible to identify the specific etiological agent. Further research in
chronic disease epidemiology on ways to measure the incubation period ofdisease may
be an important priority in etiological research.
Infectious disease epidemiology evolved out of the need to control or eliminate
epidemics (Table 10). The clinical trials of vaccines, of drug therapy, or of other
prophylactic approaches were the gold standard of infectious disease research.
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TABLE 9
What Is the Incubation Period?
Acute Diseases Chronic Diseases
1. Incubation period is an important component 1. Little interest in incubation periods ofdisease.
ofepidemiological research for identifying Primary emphasis in common source events,
specific agent and mode oftransmission. i.e., radiation exposure
2. Incubation period usually defined as median 2. Much interest in modeling evolution ofdis-
and log-normal distribution with specific dis- ease, evaluation ofinitiation and promoters,
persion factor and multi-stage progression ofdisease
3. Family studies important 3. Family studies usually related to genetic epi-
demiology
Without good clinical trials to determine the efficacy of a specific intervention, the
infectious disease epidemic model wasoften suspect. The natural experiments in which
the potential vehicle or mode of transmission was modified by non-experimental
changes in the environment have played a role in testing causal hypothesis ofa specific
agent of disease but have not really replaced the carefully well-done randomized
clinical trials.
In chronic disease epidemiology, on the other hand, observational epidemiology
appears to have a higher priority than clinical trials. In fact, except perhaps in
cardiovascular diseases, the clinical trials area has been left to the purview of the
clinicians and the biostatisticians. It is, perhaps, only in cardiovascular diseases that
the epidemiologist has played a role similar to that in infectious diseases. Natural
experiments such as migrant studies, observation oftemporal trends, and selected and
unusual changes in risk factors because of religious preferences, or social pressures,
and thelike have played a much more important role in studying theetiologyofdisease
[26,27,28,29]. There appears to be some reluctance or even hostility toward random-
ized clinical trials among chronic disease epidemiologists. The costs and the complexi-
ties ofthese trials and the need for collaborative effortsoften are not recognized within
the academic community and have probably provided some of the reasons for the
failure of chronic disease epidemiologists to pursue experimental epidemiology more
aggressively. There has never been and probably never will be a specific randomized
clinical trial in the United States to determine the effects ofsmoking cessation on the
reduction of risks of lung and other cancers. Dietary recommendations for the
TABLE 10
What Are the Methods to Control or Eliminate the Epidemic?
Acute Diseases Chronic Diseases
1. Clinical trials often considered the "Gold 1. Observational epidemiology higher priority
Standard" ofresearch than clinical trials
2. Much epidemiological research related to test- 2. Acceptance of"causal" association much
ing specific intervention, i.e., vaccine trials, more likely without clinical trials
drug trials, elimination ofvehicles oftransmis- 3. Natural experiments ofconsiderable value:
sion migrant studies, temporal trends, selective
3. Natural experiments more ofvalue in testing change in risk factors
causal hypothesis and seeking specific agent of
disease
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prevention of cancer are based on observational and some animal studies but, at the
present time, not on the results ofrandomized clinical trials. Even in the cardiovascular
field, the number of truly randomized double-blind primary prevention trials are
relatively few, considering the extensive amount ofresearch in this area.
Surveillance of disease in the population is an important component of infectious
diseaseepidemiology (Table 1 1). The evaluation ofthe success of preventive programs
depends on surveillance of infectious diseases. The Center for Disease Control has
maintained an excellent and effective method of monitoring infectious diseases in the
United States in order to determine the efficacy of various control procedures [30].
Monitoring systems of infectious diseases are often in place because of the traditional
need todetermineepidemics ofdisease asearly aspossible in order to reduce or prevent
subsequent transmission ofdisease and larger epidemics within the community.
In the chronic disease area, surveillance and evaluation ofcontrol programs are just
now being considered to be an important component. We are still dependent, however,
predominantly on trends in mortality statistics rather than on any measures of
morbidity. Long incubation periods for chronic diseases, changing criteria for defini-
tion ofdisease, and theconfounding ofmortality statistics by both changes in incidence
and case-fatality have substantially limited our ability to monitor trends in disease.
The failure to note substantial declines in cancer mortality over time has created a
great deal of concern because it has suggested that our preventive and treatment
efforts have failed. Good monitoring programs in chronic disease epidemiology are
generally dependent on an active effort to measure the incidence, mortality, and
changes in risk factors within limited areas. Such approaches have been both expensive
and restricted to limited sub-segments ofthe population.
Thereunfortunately does notappear to be a ground swell ofenthusiasm for effective
surveillance of chronic diseases in the United States. The National Cancer for Health
Statistics and, to a limited extent, several ofthe National Institutes of Health and the
Center for Disease Control have provided a limited resource for the surveillance of
chronic diseases [31]. In general, such surveillance has not been linked to tests of the
evaluation ofvarious control procedures.
Thus, there are substantial similarities and differences between chronic and
infectious diseaseepidemiology in theirapproach to the study ofdisease. The infectious
disease epidemiology model grew out of a need to control or eliminate epidemics. The
approach was much more biological, active in the sense ofseeking the specific etiology
and vehicle oftransmission based on the concepts ofone agent for each disease, and on
interactive models which separated risks into those related to the host, the specific
characteristics of the agent, and the environments which increased or decreased the
likelihood oftransmission ofdisease.
Chronic disease epidemiology initially evolved out of interest in controlling diseases
in thecommunity. As investigators recognized the complex interaction of independent
variables, a greater emphasis on the statistical methodology evolved. The longer
incubation period, possible multiple etiological variables, and difficulties of defining
subclinical disease have all contributed to our need to develop innovative methodology
and approaches to analysis. It may be worthwhile for chronic disease epidemiology to
rethink a parsimonious approach to the etiology of disease and again to consider that
each disease is causedby oneagent and to evaluateconfounding in terms ofhost, agent,
and the modes of transmission. The increasing interest of clinicians in the use of
epidemiological methods tounderstand ways ofreducing morbidity and mortality from
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TABLE 11
How Effective Are Control Procedures?
Acute Diseases Chronic Diseases
1. Surveillance ofdisease very important; shorter 1. Surveillance as evaluation ofcontrol usually
incubation periods and better definition ofdis- based on trends in mortality rather than mor-
eases enhance evaluation ofcontrol proce- bidity
dures. 2. Long incubation period and changing criteria
2. Monitoring systems often in place. Disease re- ofdisease limit evaluations.
porting by medical community traditional 3. Monitoring usually dependent upon a special
component ofcontrol because of"transmis- program in limited areas
sion" ofdisease
chronic diseases may again result in a greater emphasis on trying to understand the
etiology and specific modes of transmission and on clinical trials to evaluate the
prevention and control ofdisease. Epidemiology depends on an understanding of both
human biology and on scientific methods. Chronic disease epidemiology should
continue to emulate the best approaches developed by infectious disease epidemiolo-
gists-especially a primary goal of identifying an agent, mode of transmission, host
susceptibility, and effective control and prevention. Every study with a numerator and
a denominator is not epidemiology.
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